KRAS and neoplasm: Hu et al. utilized adoptive cell therapy in a KRAS and p53-mutated PDAC mouse model and further demonstrated that enhancing NK cell infiltration into tumors led to increased tumor necrosis and prolonged survival in PDAC mouse models, compared to controls [209].